262856 An evaluation of the National Prevention Strategy and Healthy People 2020 with targeted goals for the disabled

Sunday, October 28, 2012

Monae Johnson, MPH, MBS , Department of Health Policy and Management, School of Health Sciences & Practice, New York Medical College, Valhalla, NY
Luis Rodriguez, MD, MPH , School of Health Sciences & Practice, Department of Health Policy & Management, New York Medical College, Valhalla, NY, New York Medical College, Valhalla, NY
Mahwish Khan, MPH , School of Health Sciences & Practice, Department of Health Policy & Management, New York Medical College, Valhalla, NY
Miranda Chung, MPH , School of Health Science & Practice, Department of Health Policy & Management, New York Medical College, Valahalla, NY
Karina Aguilar, MS and MSW , Department of Health Policy & Management, School of Health Sciences & Practice, New York Medical College, Valhalla, NY
David White, MPH , School of Health Science & Practice, Department of Health Policy & Management, New York Medical College, Valhalla, NY
Deborah Viola, PhD , Department of Health Policy and Management, School of Health Sciences & Practice, Valhalla, NY
BACKGROUND: The Patient Protection and Affordable Care Act (PPACA) comprises sweeping reforms in quality, affordability and access to care for the disabled. The PPACA created the National Prevention and Health Promotion Strategy (NPS), a novel action plan with four strategic directions (creating healthy and safe communities, ensuring clinical and community preventive services, empowering people and eliminating health disparities). With a lifespan disease prevention and wellness promotion focus, the NPS targets persons unduly affected by poor health. HP 2020 has quantified targeted improvements in health equity and eliminating disparities for specific groups. Through the vehicle of the PPACA, the NPS and HP 2020 are poised to reform health care access, equity and costs for disabled persons.

METHODS: We conducted a qualitative assessment of the: NPS strategic directions, indicators and 10-year leading causes of death targets; and HP 2020 goals and objectives of 10% improvements in prevention of acute infirmity, rehabilitation and chronic disease maintenance. We hypothesized that the NPS will advance HP 2020 goals for the disabled.

FINDINGS: Several PPACA provisions (i.e. creating state exchanges and banning rescission) have established mechanisms that promote prevention and wellness for disabled persons. We found concordance between the NPS indicators, the NPS 10-year targets and the HP 2020 objectives for the disabled.

CONCLUSIONS AND IMPLICATIONS: The triangulation of strategy between the PPACA, NPS and HP 2020 can synergistically propel disease prevention and wellness promotion efforts for the disabled. This galvanizing direction can increase the numbers of disabled persons who maintain their health throughout their lifespan.

Learning Areas:
Advocacy for health and health education
Public health or related laws, regulations, standards, or guidelines

Learning Objectives:
To evaluate how the National Prevention Strategy and Healthy People 2020 goals could enhance the quality of life and health care for disabled persons.

Keywords: Disability Studies, Disability

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am a professionally trained medical writer and editor in the pharmaceutical industry after spending time as a clinical researcher at Johns Hopkins School of Medicine and the National Institutes of Health (NCI and Genetic Neuroscience Branches). With Masters degrees in both Public Health (2004) and Biomedical Sciences (2008), I am a doctoral candidate at New York Medical College (Health Policy and Management). My research interests include the childhood nutrition continuum--from hunger to obesity.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.

Back to: 2071.0: Disability Section Poster Session 4